GSK PLC closed 20.87% below its 52-week high of £18.24, which the company reached on May 16th.

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.80.

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company ...

A clear endorsement from their healthcare provider and being supplied information about recommended vaccines before their ...

GSK PLC closed 20.84% below its 52-week high of £18.24, which the company achieved on May 16th.

Alison Winder has been an assistant editor at the Royal Society of Chemistry since 2022 after several different science-based ...

The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...